This site was updated on
May 2, 2008.
 |
 |
 |
|
What’s new?
Statement by Merck & Co., Inc., Regarding the Fracture Intervention Trial (FIT) with FOSAMAX® (alendronate sodium) and Incidence of Atrial Fibrillation. For more information, click here.
If you have asthma and associated seasonal allergies, please click here for the seasonal allergy Web page.
Merck Responds to Journal of the American Medical Association Articles
For more information, click here.
Merck Frosst - Partner of the Bell Science Fair.
Click here to learn about the recipients of the Merck Frosst Award.
Merck Statement on the FDA Early Communication of an Ongoing Safety Review of Montelukast (SINGULAIR®).
For more information click here.
Dawn Graham, President of Merck Frosst, at the Canadian Club of Montreal.
For more information click here.
Merck to Seek Appellate Review of Class Certification Decision in VIOXX® Proceedings in Saskatchewan.
For more information click here.
Recent Features
New 3D anatomical models which will allow you to explore all corners of the human body. You can move these anatomical models and raise the flesh to have a full 3D effect simply by a twist of the mouse!
Click here to find out!
If you never gave chickenpox a second thought… Think again.
There is something you can do.
Help protect your child against chickenpox.
Click here to find out!
Pneumococcal pneumonia is out there
Pneumococcal pneumonia affects thousands of people in Canada each year. Click here to find out!
A New Look at Asthma
Education may be your key to taking control of your asthma. Visit our new asthma site to learn more about asthma and the treatments available.
